Kinetic studies of fluorocurcumin derivatives with anticancer activity

Two novel fluorocurcumin adducts with a difluoroboryl group exhibited activity in vitro against two bladder cancer cell lines, namely 5637 and SCaBER. The stability was evaluated under physiologically relevant conditions to mimic both the digestive tract and the bladder environment. Therefore, exper...

Full description

Saved in:
Bibliographic Details
Main Authors: Joanna Kuźmińska (Author), Agnieszka Sobczak (Author), Izabela Muszalska-Kolos (Author), Anna Jelińska (Author), Weronika Jankowska (Author), Tomasz Goslinski (Author)
Format: Book
Published: Polskie Towarzystwo Farmaceutyczne, 2023-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8c54d879933240c5ba5107d1010e5ffc
042 |a dc 
100 1 0 |a Joanna Kuźmińska  |e author 
700 1 0 |a Agnieszka Sobczak  |e author 
700 1 0 |a Izabela Muszalska-Kolos  |e author 
700 1 0 |a Anna Jelińska  |e author 
700 1 0 |a Weronika Jankowska  |e author 
700 1 0 |a Tomasz Goslinski  |e author 
245 0 0 |a Kinetic studies of fluorocurcumin derivatives with anticancer activity 
260 |b Polskie Towarzystwo Farmaceutyczne,   |c 2023-06-01T00:00:00Z. 
500 |a 0001-6837 
500 |a 10.32383/appdr/163486 
520 |a Two novel fluorocurcumin adducts with a difluoroboryl group exhibited activity in vitro against two bladder cancer cell lines, namely 5637 and SCaBER. The stability was evaluated under physiologically relevant conditions to mimic both the digestive tract and the bladder environment. Therefore, experiments were performed in hydrochloric acid at pH 1.2, and in buffer solutions with pH from 4.5 to 6.8 at 37°C. A validated HPLC method, allowing the monitoring of changes in substrates and products concentrations over time, was applied. Notably, the main decomposition product was the fluorocurcumin derivative without the difluoroboryl group. The decomposition of the fluorocurcumin adducts to the major products undergoes the pseudo-first-order kinetics reaction. 
546 |a EN 
690 |a hplc 
690 |a degradation 
690 |a validation 
690 |a kinetic studies 
690 |a fluorocurcumin derivative 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Acta Poloniae Pharmaceutica, Vol 80, Iss 2, Pp 235-244 (2023) 
787 0 |n https://www.ptfarm.pl/download/?file=File%2FActa_Poloniae%2F2023%2F2%2F235.pdf 
787 0 |n https://doaj.org/toc/0001-6837 
856 4 1 |u https://doaj.org/article/8c54d879933240c5ba5107d1010e5ffc  |z Connect to this object online.